期刊文献+

普伐他汀与阿托伐他汀对大鼠心梗后胞外基质重构及基质金属蛋白酶的影响 被引量:2

The effect of pravastatin and atorvastatin on extracellular matrix remodeling and matrix metalloproteinase after myocardial infarction in rats
暂未订购
导出
摘要 目的探讨他汀类药物对大鼠心肌梗死(MI)后胞外基质重构的作用机制,以及普伐他汀与阿托伐他汀对基质金属蛋白酶-2(MMP-2)和心室重构的影响。方法将雄性大鼠50只随机分为MI组、MI+普伐他汀组、MI+阿托伐他汀组和伪手术组。结扎冠状动脉前降支建立心肌梗死(MI)模型,在相应部位挂线不结扎作为伪手术组。8周后血流动力学检查,测量体质量(BW)、左、右心室质量(LVW,RVW);苦味酸-酸性品红染色检测非梗死区的胶原容积分数(CVF),ELISA法检测血清基质金属蛋白酶2(MMP-2)水平。结果MI组RVW/BW,LVW/BW,左室舒张末压(LVEDP)、非梗死区CVF均显著升高,MMP-2的水平亦明显升高(P均<0.05);与MI组比较,MI+他汀组的RVW/BW,LVW/BW,LVEDP,CVF显著降低,血清MMP-2水平显著减弱(P均<0.05)。两用药组间上述指标差异均无显著性(P>0.05)。结论他汀类药物缓解了MI后心肌细胞外基质的重构,其机制可能与基质金属蛋白酶(MMPs)的表达和活性调节有关。而普伐他汀与阿托伐他汀两组药物在心肌重构中差异无显著性。 Objective To investigate the statins' effect on myocardial extracellular matrix remodeling after myocardial infarction (MI) in rats,and pravastatin and atorvastatin influenced matrix metalloproteinase 2 (MMP-2) expression and ventricular remodeling.Methods Fifty rats were randomized into 4 groups:MI group,MI + pravastatin group,MI + atorvastatin group and sham-operation group.The models of MI were induced by ligated with anterior descending coronary artery;the sham-operation group was made by the same procedure without ligation.The rats were killed 8 weeks after operation to examine hemodynamic parameters,body weight (BW),left and right ventricular weight (LVW,RVW).Collagen volume fraction (CVF)was measured by using Van Gieson(VG) in noninfarcted region; the expressions of MMP-2 were detected with ELISA.Results The RVW/BW,LVW/BW,left ventricular end-diastolic pressure (LVEDP) and CVF increased significantly,and the level of MMP-2 were enhanced in MI group (P〈0.05).Compared with the MI group,RVW/BW,LVW/BW,LVEDP and CVF decreased significantly and the level of MMP-2 were weakened in the MI+statins group (P〈0.05).But there was no significant difference between the statins treated groups (P〉0.05).Conclusion Statins can prevent myocardial extracellular matrix remodeling,which is associated with the MMP-2 expressions and activities.There were no significant differences in preventing myocardial extraceltular matrix remodeling between pravastatin and atorvastatin groups.
出处 《广东药学院学报》 CAS 2007年第6期673-675,678,共4页 Academic Journal of Guangdong College of Pharmacy
关键词 普伐他汀 阿托伐他汀 细胞外基质 基质金属蛋白酶-2 pravastatin atorvastatin extracellular matrix matrix metalloproteinases-2
  • 相关文献

参考文献10

  • 1DETEN A, HOIZI A, LEICHT M. Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats [ J ]. J Mol Cell Cardiol, 2001,33(6) :1191 - 1207.
  • 2王海涛,刘昊,颜京霞,田艳霞,江小华,高俊玲.矽肺模型大鼠肺间质成纤维细胞MMP-2和MMP-9的表达[J].第四军医大学学报,2005,26(19):1751-1753. 被引量:3
  • 3BAUERSACHS J, GALUPPO P, FRACCAROLLO D, et al. Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme A reductase inhibition with eerivastatin in rats with heart failure after myocardial infarction [ J ]. Circulation,2001,104 ( 9 ) :982 - 985.
  • 4MITAL S, ZHANG X, ZHAO G, et al. Simvastatin upregulates coronary vascular endothelial nitric oxide production in conscious dogs[ J]. Am J Physiol Heart Circ Physiol,2000 ,97 ( 23 ) :2649 - 2657.
  • 5DECHEND R, FIEBELER A, PARK J K, et al. Amelioration of angiotensin II - induced cardiac injury by a 3- hydroxy-3-methylglutaryl coenzyme A reductase inhibitor [ J ]. Circulation, 2001,104 : 576 - 581.
  • 6LI Y Y, FENG Y Q, KADOKAMI T, et al. Myocardial extracel!ular matrix remodeling in transgenic mice overexpressing tumor necrosis factor can be modulated by anti-tumor necrosis factor therapy [ J]. Proc Nail Acad Sci USA ,2000,97 ( 23 ) : 12746 - 12751.
  • 7PETERSON J T,LI H ,DILLON L,et al. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat [ J ]. Cardiovasc Res, 2000,46(2) :307 -315.
  • 8曹雅旻,张志毅,傅世英.辛伐他汀对巨噬细胞基质金属蛋白酶-2、9及其组织抑制物-1、2基因表达调节的研究[J].中国急救医学,2002,22(2):92-94. 被引量:7
  • 9HASEGAMA H, YAMAMOTO R, TAKANO H, et al. 3- hydroxy-3-methylglutaryl coenzyme A reduetase inhibitors prevent the development of cardiac hypertrophy and heart failure in rats[ J]. J Mol Cell Cardiol,2003 ,35 :953 -960.
  • 10张军,贾国良,王海昌,张荣庆.卡维地洛对大鼠心肌梗塞后左室功能及胶原改建的影响[J].第四军医大学学报,2003,24(6):525-528. 被引量:6

二级参考文献11

共引文献12

同被引文献18

  • 1周裔忠,祝善俊,于林君,田颖,王江.心肌肥厚的PTEN负性调控与卡托普利干预对其影响的实验研究[J].中华心血管病杂志,2005,33(8):738-742. 被引量:12
  • 2张英俊,董兰凤,王永利.心肌肥厚:calcineurin-NFAT通路可能是新的治疗靶点[J].药学学报,2006,41(10):913-916. 被引量:3
  • 3刘军锋,贾克刚,刘运德.基质金属蛋白酶与心脏重构及心肌病理损害的研究进展[J].中华老年心脑血管病杂志,2007,9(7):499-500. 被引量:12
  • 4HUGHES S E. The pathology of hypertrophic cardiomyopathy[J]. Histopathology, 2004, 44 (5): 412-427.
  • 5GUO H, SHI Y, LIU L, et al. Rosuvastatin inhibits MMP-2 expression and limits the progression of athero- sclerosis in LDLR-deficient mice [ J]. Arch Med Res, 2009, 40 (5): 345-351,.
  • 6QU H Y, XIAO Y W, JIANG G H, et al. Effect of atorvastatin versus rosuvastatin on levels of serum lipids, inflammatory markers and adiponectin in patients with hypercholesterolemia[ J ]. Pharm Res, 2009, 26 (4) : 958-964.
  • 7BOS R, MOUGENO T N, FINDJI L, et al. Inhibition of catecholamine-induced cardiac fibrosis by an aldosterone antagonist[J]. Cardiovasc Pharm acol, 2005, 45 (1) : 8-13.
  • 8Sanguigni V, Pignatelli P, Lenti L, et al. Short - term treatment with atorvastat in reduces platelet CD40 ligand and thrombin generation in hy- per cholesterolemic patients [J]. Circulation, 2005, 111 (4):412 -419.
  • 9Tanaka K, Honda M, Takabatake T. Anti - apoptotic effect of atorvasta- tin, a 3 - hydmxy - 3 - methylglutaryl coenzyme a reductase inhibitor, on cardiac myocytes through protein kinase C activation [ J ]. Clin Exp Pharmacol Physiol, 2004, 31 (5/6): 360-364.
  • 10Ogata Y, Takalaashi M, Takeuehi K, et al. Fluvastatin induces apopto- sis in rat neonatal cardiac myocytes : a possible mechanism of statin - at- tenuated cardiac hypertrophy [J]. J Cardiovasc Pharmacol, 2002, 40 (6) : 907 -915.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部